Tuesday, January 17, 2012

Disclosing Drug Payments

The ACA was derided in part because of its length and complexity.  Funny thing is, the more we see of the health care reform the better it looks.  Here is one small measure packed into it that means a lot:  mandatory disclosure of payments to doctors from drug companies regardless of how it is accounted for.  Sales, research, kickbacks, whatever.  All of it will be subject to public review, so you can judge for yourself how closely your doctor's interests coincide with your own (at least when it comes to prescription drugs).  That might not seem like a lot until you realize you can't do that now, efforts of ProPublica not withstanding.

One of many ways the ACA reforms healthcare in America.

No comments: